Our Team

Professor of Biomedical Engineering at Yale

Dr. Fan is the founder of AtlasXomics and is the recipient of numerous awards including the Howard Temin Pathway to Independence award from NCI and the Packard Fellowship for Science and Engineering, He received a Ph.D. in Chemistry from the University of California at Berkeley, and later worked in Professor James Heath’s group at Caltech. His recent work is centered on the development of single-cell omics technologies to analyze deep functional cellular heterogeneity in human cancers and the immune system. He is the co-founder of IsoPlexis and Singleron Biotechnologies.

Associate Provost of Data Science and Information, and Dean of the School of Information, at UC Berkeley

Before joining Berkeley, Dr. Chayes was at Microsoft for over 20 years, where she was Technical Fellow, and founder and managing director of three interdisciplinary labs: Microsoft Research New England, New York City, and Montreal. She has received numerous awards for both leadership and scientific contributions, including the Anita Borg Institute Women of Vision Leadership Award, the John von Neumann Award of the Society for Industrial and Applied Mathematics, and an honorary doctorate from Leiden University. She is a member of the American Academy of Arts and Sciences and the National Academy of Sciences.

President and Professor at Institute for Systems Biology in Seattle and Professor of Molecular and Medical Pharmacology at UCLA

Dr. Heath has directed the National Cancer Institute-funded NSB Cancer Center since 2005. He received his PhD in 1988 from Rice University, where he was the principal graduate student involved in the discovery of C60 and the fullerenes — work that resulted in three senior members of his group receiving the Nobel Prize in Chemistry in 1996. Dr. Heath has founded or cofounded several companies, including PACT Pharma, Integrated Diagnostics, Indi Molecular, CTI Molecular Imaging (acquired by Siemens in 2005), Sofie Biosciences, IsoPlexis, and NanoSys.

Associate Professor of Clinical Medicine and Chemical Engineering & Material Sciences at the University of Southern California Keck School of Medicine and Viterbi School of Engineering and Chief Science and Innovation Officer for the Lawrence J. Ellison Institute for Transformative Medicine of USC

Prior to joining USC, Dr. Lee served for more than a decade as a Health Sciences Director within the National Cancer Institute’s Office of the Director. In 2016, Dr. Lee was assigned to Office of the Vice President to serve as the Deputy Director for Cancer Research and Technology for the White House Cancer Moonshot Task Force.

Professor Emeritus at the Institute for Advanced Study in Princeton

Dr. Arnold and others discovered the p53 tumor suppressor protein, a molecule that inhibits tumor development. Dr. Levine established the Simons Center for Systems Biology at the Institute for Advanced Study, concentrating on research at the interface of molecular biology and the physical sciences. He helped shape U.S. science priorities as chairman of an influential 1996 review panel on federal AIDS research funding. He also chaired the National Cancer Advisory Board, which advises the National Academy of Sciences and its Institute of Medicine on cancer policy.